2FDA.Use in Medical Product Development to Support Labeling Claims [EB/OL].(2009-12-01 )[2013-11-06].http://www.fda.gov/search/ Guidance for Industry-patient-Reported Outcome Measures.
3Garvey T A, Marks M R. A prospective, randomized, double- blind evaluation of trigger point injection therapy for low-back pain [J]. Spine ,1989,14 (5): 962-966.
4Smith L A, Oldman A D, McQuay H J, et al. Teasing apart quality and validity in systematic reviews: an example from acupuncture trials in chronic neck and back pain [J]. Pain, 2000, 86 (2):119-132.
6U.S. Food and Drug Administration. FDA's Clinical Investigator Training Course[EB/OL]. [2013-11-06].http://www.fda.gov/Sci- enceResearch/SpecialTopics/CriticalPathlnitiative/SpotlightonCP- IProjects/ucm201459.htm.
7Clinical investigator training workshop. Clinical investigator train- ing workshop: in collaboration with Society of Clinical Research Professionals Malaysia[EB/OL].[2013-11-06].http://www.crestev- endLcom.my/web/overview.
